13 Jul 2020 14:39
4D Pharma To Raise GBP7.7 Million In Share Issue, Eyes US Listing
4D Pharma To Raise GBP7.7 Million In Share Issue, Eyes US Listing
Read more
- Home
- Share Prices
- AQSE Share Prices
- Euronext
- Stock Screeners
- Share Chat
- FX
- News & RNS
- Events
- Media
- Trading Brokers
- Finance Tools
- Members
Latest Share Chat
DDDD.L Share News (DDDD)
DDDD Share
Price
DDDD Share
News
DDDD Share
Chat
DDDD Share
Trades
DDDD
Live RNS
DDDD Share
Charts
DDDD Broker
Ratings
DDDD Directors
Deals
DDDD Financial
Diary
DDDD
Fundamentals
DDDD Short
Positions
DDDD
Media
DDDD.L Information
- There is currently no data for DDDD
Watchlists are a member only feature
Login to your account
Don't have an account? Click here to register.6 Jul 2020 12:38
Next part of tumour trial begins for 4D Pharma
(Sharecast News) - Biotherapeutics developer 4D Pharma has begin the treatment of the first patients in part B of its phase 1 and 2 clinical trial of 'MRx0518' in combination with immune checkpoint inhibitor 'Keytruda', or pembrolizumab, it announced on Monday, in patients with acquired resistance to prior immune checkpoint therapy.
Read more6 Jul 2020 10:17
4D Pharma Starts Treatment Of Patients In Phase 2 Of MRx0518 Trial
4D Pharma Starts Treatment Of Patients In Phase 2 Of MRx0518 Trial
Read more2 Jul 2020 12:14
Patient enrolment begins for 4D's Covid therapy candidate
(Sharecast News) - Biotherapeutics-focussed pharmaceutical company 4D Pharma announced on Thursday that its phase 2 clinical trial of the oral immunomodulator 'MRx-4DP0004', for patients hospitalised with Covid-19, was now open to enrolment, with dosing of the first patients expected shortly.
Read more2 Jul 2020 09:16
4d Pharma Starts Covid-19 Patients Enrollment For MRx-4DP0004 Study
4d Pharma Starts Covid-19 Patients Enrollment For MRx-4DP0004 Study
Read more26 May 2020 10:06
4d Pharma Reports Revenue For 2019 But Loss Widens On Higher Costs
4d Pharma Reports Revenue For 2019 But Loss Widens On Higher Costs
Read more11 May 2020 10:45
4D Pharma Completes First Part Of Clinical Trial For Cancer Treatment
4D Pharma Completes First Part Of Clinical Trial For Cancer Treatment
Read more20 Apr 2020 11:08
4D Pharma receives expedited approval for coronavirus study
(Sharecast News) - Pharmaceutical company 4D Pharma received expedited acceptance from the UK Medicines and Healthcare Products Regulatory Agency on Monday to kick off a Phase II study of MRx-4DP0004 in patients with Covid-19.
Read more20 Apr 2020 10:30
4D Pharma Stock Jumps 60% As Gets Approval For Study Of Covid-19 Drug
4D Pharma Stock Jumps 60% As Gets Approval For Study Of Covid-19 Drug
Read more17 Apr 2020 13:53
4D Pharma upbeat on key findings from Blautix study
(Sharecast News) - Biotherapeutics-focussed pharmaceutical company 4D Pharma announced key findings of a planned interim analysis in its 'BHT-II-0002' study in irritable bowel syndrome (IBS) on Friday.
Read more17 Apr 2020 10:14
4D Pharma Appoints New Chair, Reports Encouraging Blautix Trial Data
4D Pharma Appoints New Chair, Reports Encouraging Blautix Trial Data
Read more18 Mar 2020 18:09
DIRECTOR DEALINGS SUMMARY: Wizz Air Chair Buys GBP700,000 In Shares
DIRECTOR DEALINGS SUMMARY: Wizz Air Chair Buys GBP700,000 In Shares
Read more18 Feb 2020 18:44
UPDATE:4d Pharma Raises GBP22 Million Through Placing And Subscription
UPDATE:4d Pharma Raises GBP22 Million Through Placing And Subscription
Read more18 Feb 2020 09:26
4D Pharma raising at least ?18m via placing and subscription
(Sharecast News) - Live biotherapeutic pharmaceutical company 4D Pharma announced a proposed fundraising on Tuesday, by way of a placing and subscription of new ordinary shares and warrants, to raise gross proceeds of at least ?18m via an accelerated bookbuild process.
Read more18 Feb 2020 09:03
4d Pharma Plans GBP18 Million Fundraise To Fund Clinical Studies
4d Pharma Plans GBP18 Million Fundraise To Fund Clinical Studies
Read more